|
Receptor Activity-Modifying Protein 1
|
D12.776.476.024.414.100 |
|
|
Receptor Activity-Modifying Proteins
|
D12.776.476.024.414 |
|
|
Oncostatin M
|
D12.644.276.374.562 |
|
|
Janus Kinase 2
|
D12.776.624.664.700.117 |
|
|
fms-Like Tyrosine Kinase 3
|
D12.776.624.664.700.114 |
|
|
G2 Phase
|
D016195 |
[The period of the CELL CYCLE following DNA synthesis (S PHASE) and preceding M PHASE (cell division phase). The CHROMOSOMES are tetraploid in this point.
] |
|
Microtubule Proteins
|
D12.776.220.600 |
|
|
S Phase
|
D016196 |
[Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome.
] |
|
Palliative Medicine
|
D065126 |
[A branch of medicine concerned with preventing and relieving the suffering of patients in any stage of disease. Its focus is on comprehensive care and improving the quality of all areas of the patient's life.
] |
|
Dopamine D2 Receptor Antagonists
|
D065127 |
[Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS.
] |
|
Deoxyribonuclease HpaII
|
D08.811.277.352.355.325.300.260.300 |
|
|
Dental High-Speed Equipment
|
E06.186.376 |
|
|
Endothelin Receptor Antagonists
|
D065128 |
[Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS.
] |
|
Ammotherapy
|
E02.056.020 |
|
|
Balneology
|
E02.056 |
|
|
Pre-Exposure Prophylaxis
|
D065129 |
[A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.
] |
|
Carboplatin
|
D016190 |
[An organoplatinum compound that possesses antineoplastic activity.
] |
|
Receptors, Granulocyte Colony-Stimulating Factor
|
D016188 |
[Receptors that bind and internalize GRANULOCYTE COLONY-STIMULATING FACTOR. Their MW is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.
] |
|
KRIT1 Protein
|
D12.776.624.664.700.119 |
|
|
Dystrophin
|
D016189 |
[A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.
] |
